HUTCHMED (China) Limited
HCM
$14.20
-$0.10-0.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -16.54% | -16.54% | -9.16% | -9.16% | -32.22% |
| Total Other Revenue | -- | -- | -- | -- | 21.10% |
| Total Revenue | -16.54% | -16.54% | -9.16% | -9.16% | 6.36% |
| Cost of Revenue | -16.75% | -16.75% | -6.97% | -6.97% | -20.34% |
| Gross Profit | 17.94% | 17.94% | -12.30% | -12.30% | 67.43% |
| SG&A Expenses | 11.44% | 11.44% | -28.00% | -28.00% | -15.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.04% | -10.04% | -15.61% | -15.61% | -14.48% |
| Operating Income | -120.25% | -120.25% | 87.23% | 87.23% | 82.65% |
| Income Before Tax | -83.91% | -83.91% | 1,685.54% | 1,685.54% | 124.49% |
| Income Tax Expenses | -89.60% | -89.60% | 2,088.57% | 2,088.57% | 142.05% |
| Earnings from Continuing Operations | -81.87% | -81.87% | 1,641.09% | 1,641.09% | 117.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -188.31% | -188.31% | -65.11% | -65.11% | -112.77% |
| Net Income | -83.61% | -83.61% | 1,663.32% | 1,663.32% | 117.60% |
| EBIT | -120.25% | -120.25% | 87.23% | 87.23% | 82.65% |
| EBITDA | -181.88% | -181.88% | 112.24% | 112.24% | 88.64% |
| EPS Basic | -84.29% | -84.29% | 1,657.62% | 1,657.62% | 117.59% |
| Normalized Basic EPS | -96.10% | -96.10% | 41.35% | 41.35% | 135.16% |
| EPS Diluted | -98.00% | -98.00% | 1,633.33% | 1,633.33% | 112.56% |
| Normalized Diluted EPS | -96.00% | -96.00% | 41.18% | 41.18% | 134.25% |
| Average Basic Shares Outstanding | 0.57% | 0.57% | 0.12% | 0.12% | 0.27% |
| Average Diluted Shares Outstanding | 0.01% | 0.01% | 0.00% | 0.00% | 2.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |